Ibogaine By David Dardashti Unravels the Science of Glial Cells
February 23, 2024 15:13 ET
|
Ibogaine By David Dardashti
MIAMI, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a scientific research organization based in the United States, is excited to reveal the findings from their groundbreaking study...
Ibogaine By David Dardashti Improves Dosing Efficiency Through Engineering Statistics
February 07, 2024 21:06 ET
|
Ibogaine By David Dardashti
MIAMI, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a revolutionary facility dedicated to the research of ibogaine and its efficacy, has developed a more efficient way of...
Ibogaine By David Dardashti Shares Insight On New Study By Stanford University
February 01, 2024 07:39 ET
|
Ibogaine By David Dardashti
MIAMI, Feb. 01, 2024 (GLOBE NEWSWIRE) -- According to researchers at Stanford University, ibogaine may have the potential to restore brain function in individuals who have suffered traumatic brain...
Ibogaine By David Dardashti Analyzes Connections Between Physical and Emotional Pain
January 15, 2024 18:21 ET
|
Ibogaine By David Dardashti
Ibogaine By David Dardashti presents a relationship between emotional and physical pain.
The Virtual Trip Showcases Veterans Sessions from Psychedelic Science 2023 in Honor of Veterans Day
November 11, 2023 01:46 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
Eight virtual conference sessions explore psychedelic research for Veterans including trauma support, federal backing, and a pilot study on Ibogaine
MagicMed Industries to Present at the Q1 Virtual Investor Summit
March 19, 2021 08:15 ET
|
MagicMed Industries Inc.
CALGARY, Alberta, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused on creating novel psychedelic...